Ralph Smalling - 01 Sep 2025 Form 4 Insider Report for GENELUX Corp (GNLX)

Role: Head of Regulatory
Signature: /s/ Thomas Zindrick, J.D.Attorney-in-Fact
Issuer symbol: GNLX
Transactions as of: 01 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Sep 2025, 16:15:31 UTC
Previous filing: 29 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Smalling Ralph	Head of Regulatory	C/O GENELUX CORPORATION, 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE	/s/ Thomas Zindrick, J.D.Attorney-in-Fact	03 Sep 2025	0001983288

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GNLX	Common Stock	Award	$0	+10,000	+16%	$0.000000	70,990	01 Sep 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GNLX	Stock Option (Right to Buy)	Disposed to Issuer		-8,333	-100%		0	01 Sep 2025	Common stock	8,333	$6.00	Direct	F2, F3
transaction	GNLX	Stock Option (Right to Buy)	Award		+8,333			8,333	01 Sep 2025	Common stock	8,333	$3.33	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common Stock upon vesting. The RSUs will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 12 equal quarterly (every 3 months) installments thereafter.
F2	The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.
F3	The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option.